Advanced wound care items are specially designed to heal the complex wound faster than as compared to the traditional techniques that look longer time. These products are essentially covered under insurance, requiring the doctor’s regulation. This includes the alginates, the hydrogels, hydrocolloids, foam dressings and film dressings. The advanced healing process includes the inflammatory stage, the fibroblastic stage, and the maturation stage, also known as the strengthening stage. Nonetheless, there are also few constraints that could slow down the healing process, such as medical conditions, hemorrhage, infection, mechanical damage, age, dryness, diet, dead skin, smoking, varicose veins, and more.
Advanced wound care market is estimated to be over US$ 8.5 Bn in 2017. It is anticipated to grow at a CAGR of 4.3% from 2019 to 2030.
Technological advancements in the sector of wound therapy, growing geriatric population and treatment coupled with increasing awareness among patients have been pivotal in dictating the growth of the advanced wound care market. Moreover, efficient treatment options for complex wounds, diabetes and associated chronic wounds and increasing expenditures on healthcare is anticipated to be the major drive the growth of the global advanced wound care market between 2019 and 2030.Furthermore, key players have extensively focused on collaborating with several educational and research institutes to amplify R&D activities and meet the overall demands of the healthcare industry. For instance, Smith and Nephew a global medical device company entered into collaboration with University of Hull, to create wound care research cluster and facilitate development of advanced R&D centers.
Major Key Players of the Advanced Wound Care Market are:
Smith & Nephew, B. Braun, ConvaTec Group, Integra LifeSciences, 3M, Cardinal Health, Medtronic, MPM Medical, Paul HARTMANN, and MiMedx Group, among others.
No comments:
Post a Comment